Abstract:Background: Receptor tyrosine kinase (RTK) inhibitors as novel anticancer therapy are associated with clinical heart failure. Better understanding molecular mechanisms underlying such a side effect may provide new strategies to prevent RTK inhibitors-induced heart failure. Grb2-associated binder 1 (Gab1), a member of the docking protein family, is a central mediator for RTK signaling. We hypothesized that the deletion of Gab1 causes dilated cardiomyopathy and heart failure. Methods and Results: Using alpha-MHC-Cre mice and Gab1 loxp mice, we generated cardiac-specific Gab1 knockout (Gab1-cKO) mice. Gab1-cKO mice were viable and born at the expected Mendelian ratio. With echocardiography, hemodynamic measurements and histological analysis, we found that cardiac Gab1 deficiency in mice caused progressive dilated cardiomyopathy and heart failure. At age 3-6 months, ejection fraction and dp/dt max in Gab1-cKO mice were considerably lower than those in Gab1 wild-type littermates. Moreover, under mechanical stress via transverse aortic constriction at young age (around 6 weeks) before onset of heart failure, Gab1-cKO mice suffered more severe dilated cardiomyopathy and induced lethality. The deletion of Gab1 in heart during adulthood by crossing Gab1-loxp mice with tamaxifen-inducible alpha-MHC-Cre mice also resulted in cardiac dysfunction and heart failure. Mechanistically, we observed loss of mitochondrial membrane potential and increase of cardiomyocyte apoptosis in Gab1-cKO heart. Transmission electronic microscopy studies showed frequent damaged mitochondria with cristae lysis and apparent abnormal internal membrane whorls in Gab1-cKO heart. Signaling studies revealed that proapoptotic genes including p38 and caspase 3 were overly activated in Gab1-cKO heart. Gene array and quantitative PCR analysis showed that antiapoptotic genes such as Bcl2 were downregulated, whereas proapopotic genes such Bnip3 were upregulated in Gab1-cKO heart. Conclusion: Gab1 is a crucial regulator of cardiac function through maintaining mitochondrial integrity and cell survival, suggesting that the preservation of Gab1 signaling could be one of therapeutic strategies to prevent heart failure induced by anticancer RTK inhibitors.

Grb2-associated binder 1 is essential for cardioprotection against ischemia/reperfusion injury

ER Chaperone GRP78 Protects Heart from Ischemia/Reperfusion Injury Through Akt Activation.

Glucose-regulated Protein 78 is Essential for Cardiac Myocyte Survival

TANK-binding Kinase 1 Alleviates Myocardial Ischemia/reperfusion Injury Through Regulating Apoptotic Pathway.

Grb-2-associated Binder 1 (gab1) Regulates Postnatal Ischemic and VEGF-induced Angiogenesis Through the Protein Kinase A-endothelial NOS Pathway.

Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis.

Abstract 16959: Cardiac Grb2-associated Binder 1 Deficiency Causes Dilated Cardiomyopathy and Heart Failure Due to Severe Mitochondrial Damage and Cardiomyocyte Apoptosis

Inhibition of Endoplasmic Reticulum Stress by Neuregulin-1 Protects Against Myocardial Ischemia/reperfusion Injury

The Protective Role of Bfgf in Myocardial Infarction and Hypoxia Cardiomyocytes by Reducing Oxidative Stress Via Nrf2

Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways

Abstract 164: Endothelial Gab1 Limits Vascular Remodeling and Atherosclerosis Through Inhibition of Endothelial Inflammation

HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury Via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression

Ginsenoside Rg1 Ameliorates Rat Myocardial Ischemia-Reperfusion Injury by Modulating Energy Metabolism Pathways

Vascular Endothelial Growth Factor-C Protects Heart from Ischemia/reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis

Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis

Endogenous basic fibroblst growth factor is a protective factor against myocardial ischemia/reperfusion injury of rats

Glutaredoxin 2 Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Injury by Suppressing Apoptosis, Oxidative Stress, and Inflammation Via Enhancing Nrf2 Signaling.

Ginsenoside Rb1 protects against ischemia/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway

Cellular Repressor of E1A-Stimulated Genes Protects From Myocardial Ischemia/Reperfusion Injury by Regulating Myocardial Autophagy and Apoptosis

Beclin1 controls caspase-4 inflammsome activation and pyroptosis in mouse myocardial reperfusion-induced microvascular injury

Regulator of G-protein Signaling 5 Protects Cardiomyocytes Against Apoptosis During in Vitro Cardiac Ischemia-Reperfusion in Mice by Inhibiting Both JNK1/2 and P38 Signaling Pathways.